Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 7, 2016

Primary Completion Date

February 25, 2019

Study Completion Date

February 25, 2019

Conditions
Primary Sclerosing CholangitisPost- Orthotopic Liver Transplantation
Interventions
DRUG

Vancomycin

Vancomycin belongs to the family of medicines called antibiotics.When taken by mouth, is used to treat Clostridium difficile-associated diarrhea (also called C diff). C diff is a type of bacteria that causes severe diarrhea. Oral Vancomycin is also used to treat enterocolitis caused by a certain bacteria (e.g., Staphylococcus aureus). Subjects enrolled in the study will take 500 mg capsule, 3 times per day for 3-12 weeks.

Trial Locations (1)

70121

Ochsner Medical Center, New Orleans

Sponsors
All Listed Sponsors
lead

Ochsner Health System

OTHER